Gobika Thiripuranathar

Dr. Gobika Thiripuranathar

Institute of Chemistry
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Farid MenaaFarid Menaa
Farid Menaa
Udari WijesingheUdari Wijesinghe
Udari Wijesinghe
Gobika ThiripuranatharGobika Thiripuranathar
Gobika Thiripuranathar
NANorah Ayidh Althobaiti
Norah Ayidh Althobaiti
AAAishah E. Albalawi
Aishah E. Albalawi
BMBouzid Menaa
Bouzid Menaa
Marine algae are rich in bioactive nutraceuticals (e.g., carbohydrates, proteins, minerals, fatty acids, antioxidants, and pigments). Biotic (e.g., plants, microorganisms) and abiotic factors (e.g., temperature, pH, salinity, light intensity) contribute to the production of primary and secondary metabolites by algae. Easy, profitable, and sustainable recovery methods include novel solid-liquid and liquid-liquid extraction techniques (e.g., supercritical, high pressure, microwave, ultrasound, enzymatic). The spectacular findings of algal-mediated synthesis of nanotheranostics has attracted further interest because of the availability of microalgae-based natural bioactive therapeutic compounds and the cost-effective commercialization of stable microalgal drugs. Algal extracts can serve as stabilizing/capping and reducing agents for the synthesis of thermodynamically stable nanoparticles (NPs). Different types of nanotherapeutics have been synthesized using physical, chemical, and biological methods. Marine algae are a fascinating source of lead theranostics compounds, and the development of nanotheranostics has been linked to enhanced drug efficacy and safety. Indeed, algae are remarkable nanobiofactories, and their pragmatic properties reside in their (i) ease of handling; (ii) capacity to absorb/accumulate inorganic metallic ions; (iii) cost-effectiveness; and (iv) capacity of eco-friendly, rapid, and healthier synthesis of NPs. Preclinical and clinical trials shall enable to really define effective algal-based nanotherapies. This review aims to provide an overview of the main algal compounds that are nutraceuticals and that can be extracted and purified for nanotheranostic purposes.

16 October 2020 in Bioengineering
Verified
Journal Article
Open access
PDF file
Bushra UzairBushra Uzair
Bushra Uzair
ALAyesha Liaqat
Ayesha Liaqat
HIHaroon Iqbal
Haroon Iqbal
BMBouzid Menaa
Bouzid Menaa
ARAnam Razzaq
Anam Razzaq
Farid MenaaFarid Menaa
Farid Menaa
Metal nanoparticles (NPs) have received much attention for potential applications in medicine (mainly in oncology, radiology and infectiology), due to their intriguing chemical, electronical, catalytical, and optical properties such as surface plasmon resonance (SPR) effect. They also offer ease in controlled synthesis and surface modification (e.g., tailored properties conferred by capping/protecting agents including N-, P-, COOH-, SH-containing molecules and polymers such as thiol, disulfide, ammonium, amine, and multidentate carboxylate), which allows (i) tuning their size and shape (e.g., star-shaped and/or branched) (ii) improving their stability, monodispersity, chemical miscibility, and activity, (iii) avoiding their aggregation and oxidation over time, (iv) increasing their yield and purity. The bottom-up approach, where the metal ions are reduced in the NPs grown in the presence of capping ligands, has been widely used compared to the top-down approach. Besides the physical and chemical synthesis methods, the biological method is gaining much consideration. Indeed, several drawbacks have been reported for the synthesis of NPs via physical (e.g., irradiation, ultrasonication) and chemical (e.g., electrochemisty, reduction by chemicals such as trisodium citrate or ascorbic acid) methods (e.g., cost, and/ortoxicity due to use of hazardous solvents, low production rate, use of huge amount of energy). However, (organic or inorganic) eco-friendly NPs synthesis exhibits a sustainable, safe, and economical solution. Thereby, a relatively new trend for fast and valuable NPs synthesis from (live or dead) algae (i.e., microalgae, macroalgae and cyanobacteria) has been observed, especially because of its massive presence on the Earth’s crust and their unique properties (e.g., capacity to accumulate and reduce metallic ions, fast propagation). This article discusses the algal-mediated synthesis methods (either intracellularly or extracellularly) of inorganic NPs with special emphasis on the noblest metals, i.e., silver (Ag)- and gold (Au)-derived NPs. The key factors (e.g., pH, temperature, reaction time) that affect their biosynthesis process, stability, size, and shape are highlighted. Eventually, underlying molecular mechanisms, nanotoxicity and examples of major biomedical applications of these algal-derived NPs are presented.

8 September 2022 in Sustainability
Verified
Journal Article
Open access
PDF file
BGBachir Gherbi
Bachir Gherbi
SLSalah Eddine LAOUINI
Salah Eddine LAOUINI
MSMENECEUR Souhaila
MENECEUR Souhaila
ABDERRHMANE BOUAFIAABDERRHMANE BOUAFIA
ABDERRHMANE BOUAFIA
HEMMAMI HadiaHEMMAMI Hadia
HEMMAMI Hadia
Farid MenaaFarid Menaa
Farid Menaa
In this paper, ZnO nanoparticles (NPs) were greenly synthesized at different pH values of 4, 6, 9.5, and 11 via Portulaca oleracea leaf extract, and the effect of pH on the optical and structural properties was studied. UV-Vis spectrophotometers and FTIR spectroscopy characterized the optical properties. Meanwhile, the structural properties were characterized via Scanning Electron Microscopy (SEM) and X-ray Diffraction (XRD). Furthermore, their photocatalytic dye degradation was examined against methyl orange dye. The characterization results have confirmed the successful biosynthesis of ZnO nanoparticles with a size ranging between 22.17 to 27.38 nm. The synthesis pH value significantly influenced ZnO NPs’ optical and morphological properties. The results have also indicated the high performance of the greenly synthesized ZnO NPs for dye degradation.

14 December 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Farid MenaaFarid Menaa
Farid Menaa
PWP. A. U. I. Wijesinghe
P. A. U. I. Wijesinghe
Gobika ThiripuranatharGobika Thiripuranathar
Gobika Thiripuranathar
Bushra UzairBushra Uzair
Bushra Uzair
HIHaroon Iqbal
Haroon Iqbal
BMBouzid Menaa
Bouzid Menaa
Seaweeds are broadly distributed and represent an important source of secondary metabolites (e.g., halogenated compounds, polyphenols) eliciting various pharmacological activities and playing a relevant ecological role in the anti-epibiosis. Importantly, host (as known as basibiont such as algae)–microbe (as known as epibiont such as bacteria) interaction (as known as halobiont) is a driving force for coevolution in the marine environment. Nevertheless, halobionts may be fundamental (harmless) or detrimental (harmful) to the functioning of the host. In addition to biotic factors, abiotic factors (e.g., pH, salinity, temperature, nutrients) regulate halobionts. Spatiotemporal and functional exploration of such dynamic interactions appear crucial. Indeed, environmental stress in a constantly changing ocean may disturb complex mutualistic relations, through mechanisms involving host chemical defense strategies (e.g., secretion of secondary metabolites and antifouling chemicals by quorum sensing). It is worth mentioning that many of bioactive compounds, such as terpenoids, previously attributed to macroalgae are in fact produced or metabolized by their associated microorganisms (e.g., bacteria, fungi, viruses, parasites). Eventually, recent metagenomics analyses suggest that microbes may have acquired seaweed associated genes because of increased seaweed in diets. This article retrospectively reviews pertinent studies on the spatiotemporal and functional seaweed-associated microbiota interactions which can lead to the production of bioactive compounds with high antifouling, theranostic, and biotechnological potential.

6 July 2022 in Chemosphere
Verified
Journal Article
Closed access
Kandasamy SaravanakumarKandasamy Saravanakumar
Kandasamy Saravanakumar
SSShanali De Silva
Shanali De Silva
SSSugavaneswaran Siva Santosh
Sugavaneswaran Siva Santosh
Anbazhagan SathiyaseelanAnbazhagan Sathiyaseelan
Anbazhagan Sathiyaseelan
AGArchchana Ganeshalingam
Archchana Ganeshalingam
MWMyeong-Hyeon Wang
Myeong-Hyeon Wang

12 October 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Kandasamy SaravanakumarKandasamy Saravanakumar
Kandasamy Saravanakumar
SPSeonJu Park
SeonJu Park
SSSugavaneswaran Siva Santosh
Sugavaneswaran Siva Santosh
AGArchchana Ganeshalingam
Archchana Ganeshalingam
Gobika ThiripuranatharGobika Thiripuranathar
Gobika Thiripuranathar
MWMyeong-Hyeon Wang
Myeong-Hyeon Wang